Psychopharmacological treatment for military posttraumatic stress disorder: an integrative review - PubMed (original) (raw)
Review
. 2013 Aug;25(8):419-423.
doi: 10.1111/1745-7599.12016. Epub 2013 Mar 6.
Affiliations
- PMID: 24170638
- DOI: 10.1111/1745-7599.12016
Review
Psychopharmacological treatment for military posttraumatic stress disorder: an integrative review
Jennifer Tawa et al. J Am Assoc Nurse Pract. 2013 Aug.
Abstract
Purpose: Posttraumatic stress disorder (PTSD) is a serious mental health disorder. The current first-line psychopharmacologic treatment for PTSD is selective serotonin reuptake inhibitors (SSRIs). Recently, the efficacy of SSRIs has been challenged in favor of propranolol use. This article reviews the origins of PTSD, its impact within the veteran population, psychopharmacological treatment of PTSD, and current literature on the use of propranolol for PTSD treatment.
Data sources: The search strategies used included ProQuest, Medline, CINAHL, and Psychiatry Online and were searched using the key terms: PTSD, psychopharmacological treatment, SSRIs, propranolol, military, and veterans in multiple combinations.
Conclusions: Studies to date indicate that (a) SSRIs are only moderately effective as a first-line treatment for PTSD and less so for military personnel, (b) propranolol has the ability to attenuate traumatic memory in primary and tertiary use, and (c) ethical and moral consideration as well as further research and testing is needed for substantiating propranolol as a first-line PTSD psychopharmacological treatment.
Implications for practice: Current research has shown propranolol to be an effective treatment option for PTSD.
Keywords: Posttraumatic stress disorder (PTSD); pharmacotherapy; selective serotonin reuptake inhibitors (SSRI); treatment; veterans.
©2013 The Author(s) ©2013 American Association of Nurse Practitioners.
Similar articles
- Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?
Bernardy NC, Friedman MJ. Bernardy NC, et al. Curr Psychiatry Rep. 2015 Apr;17(4):564. doi: 10.1007/s11920-015-0564-2. Curr Psychiatry Rep. 2015. PMID: 25749751 Review. - Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review.
Strawn JR, Keeshin BR, DelBello MP, Geracioti TD Jr, Putnam FW. Strawn JR, et al. J Clin Psychiatry. 2010 Jul;71(7):932-41. doi: 10.4088/JCP.09r05446blu. Epub 2010 Apr 20. J Clin Psychiatry. 2010. PMID: 20441729 Review. - Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms.
Spangler PT, West JC, Dempsey CL, Possemato K, Bartolanzo D, Aliaga P, Zarate C, Vythilingam M, Benedek DM. Spangler PT, et al. J Clin Psychiatry. 2020 Oct 27;81(6):20m13233. doi: 10.4088/JCP.20m13233. J Clin Psychiatry. 2020. PMID: 33113596 Free PMC article. Clinical Trial. - Pharmacotherapy for posttraumatic stress disorder at a Veterans Affairs facility.
Kobayashi TM, Patel M, Lotito M. Kobayashi TM, et al. Am J Health Syst Pharm. 2015 Jun 1;72(11 Suppl 1):S11-5. doi: 10.2146/ajhp150095. Am J Health Syst Pharm. 2015. PMID: 25991587
Cited by
- Metabolic and immune dysfunctions in post-traumatic stress disorder: what can we learn from animal models?
Lushchak O, Orru M, Strilbytska O, Berezovskyi V, Cherkas A, Storey KB, Bayliak M. Lushchak O, et al. EXCLI J. 2023 Sep 4;22:928-945. doi: 10.17179/excli2023-6391. eCollection 2023. EXCLI J. 2023. PMID: 38023568 Free PMC article. Review. - Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder.
Szeleszczuk Ł, Frączkowski D. Szeleszczuk Ł, et al. Int J Mol Sci. 2022 Sep 3;23(17):10099. doi: 10.3390/ijms231710099. Int J Mol Sci. 2022. PMID: 36077489 Free PMC article. Review. - URB597 induces subtle changes to aggression in adult Lister Hooded rats.
Warren WG, Hale E, Papagianni EP, Cassaday HJ, Stevenson CW, Stubbendorff C. Warren WG, et al. Front Psychiatry. 2022 Aug 12;13:885146. doi: 10.3389/fpsyt.2022.885146. eCollection 2022. Front Psychiatry. 2022. PMID: 36032247 Free PMC article. - Comparison of cannabidiol to citalopram in targeting fear memory in female mice.
Montoya ZT, Uhernik AL, Smith JP. Montoya ZT, et al. J Cannabis Res. 2020 Dec 11;2(1):48. doi: 10.1186/s42238-020-00055-9. J Cannabis Res. 2020. PMID: 33526146 Free PMC article. - Noradrenergic Modulation of Fear Conditioning and Extinction.
Giustino TF, Maren S. Giustino TF, et al. Front Behav Neurosci. 2018 Mar 13;12:43. doi: 10.3389/fnbeh.2018.00043. eCollection 2018. Front Behav Neurosci. 2018. PMID: 29593511 Free PMC article. Review.
References
- Antai-Otong, D. (2007). Pharmacologic management of posttraumatic stress disorder. Perspectives in Psychiatric Care, 43(1), 55–59.
- Birbaum, A. (2007). Jacob and Joseph: A biblical case study of post traumatic stress disorder. Journal of Aggression, Maltreatment, and Trauma, 14(4), 74–86.
- Brunet, B., Orr, S. P., Tremblay, J., Robertson, K., Nader, K., & Pitman, R. K. (2008). Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script driven traumatic imagery in post traumatic stress disorder. Journal of Psychiatric Research, 42, 503–506.
- Callahan, D. J. (2010). Combat-related mental health disorders: The case for resiliency in the long war. Journal of the American Osteopathic Association, 110(9), 520–527.
- Davis, L. L., Frazier, E. C., Williford, R. B., & Newell, J. M. (2006). Long term pharmacotherapy for post-traumatic stress disorder. CNS Drugs, 20(6), 465–476.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical